Molbio Diagnostics IPO Subscription Status
Molbio Diagnostics IPO subscription status opens on 10 August 2026. Live QIB, NII, Retail, SHNI, and BHNI numbers will appear once bidding starts.
Allotment date is 13 August 2026. Listing date on NSE and BSE is 17 August 2026.
Issue Price
Rs 807.00
GMP Today
Rs 170.00 (+21.07%)
Overall Subscription
-
Issue Size
₹939.70 Cr
Allotment Date
13 Aug 2026
Listing Date
17 Aug 2026
Molbio Diagnostics IPO Allotment Chances
Molbio Diagnostics IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
Allotment chances will show here once subscription data is live.
Check the Molbio Diagnostics IPO Allotment Status page from 13 August 2026 for your result.
Molbio Diagnostics IPO GMP After Subscription
GMP for Molbio Diagnostics IPO stands at Rs 170.00 today, giving an estimated listing price of Rs 977.00 per share.
Track live GMP on the Molbio Diagnostics IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Molbio Diagnostics IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 10 August 2026 |
| IPO Close Date | 12 August 2026 |
| Allotment Date | 13 August 2026 |
| Refund Initiation | 14 August 2026 |
| Share Credit to Demat | 14 August 2026 |
| Listing Date | 17 August 2026 |
| Minimum Investment | Rs 14,526.00 |
| Lot Size | 18 shares |
About Molbio Diagnostics IPO
No company information available
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Molbio Diagnostics IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Molbio Diagnostics IPO Details
Issue size, price, financials, and company info
Molbio Diagnostics IPO GMP
Live grey market premium and listing estimate
Molbio Diagnostics IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Molbio Diagnostics IPO Allotment
Allotment date, chances, and check by PAN
Molbio Diagnostics IPO Review
SWOT, strengths, risks, and IPO review
Molbio Diagnostics IPO FAQ
Common questions on dates, GMP, and allotment
Molbio Diagnostics IPO Registrar
Registrar website and how to check allotment
Molbio Diagnostics IPO Timeline
Open, close, allotment, and listing dates
Molbio Diagnostics IPO News
Updates, blogs, and latest IPO news
Molbio Diagnostics IPO Subscription FAQs
What is Molbio Diagnostics IPO subscription status today?
Molbio Diagnostics IPO overall subscription is - today (by shares). QIB N/A, NII N/A, Retail N/A. Live updates from 10 August 2026 to 12 August 2026.
What is the overall subscription of Molbio Diagnostics IPO?
Molbio Diagnostics IPO overall subscription data is not available yet. Figures update once bidding starts on 10 August 2026.
What is Molbio Diagnostics IPO QIB subscription?
QIB subscription for Molbio Diagnostics IPO will appear here once institutional bids are recorded.
What is Molbio Diagnostics IPO Retail subscription?
Retail subscription for Molbio Diagnostics IPO is not live yet.
What is Molbio Diagnostics IPO NII, SHNI, and BHNI subscription?
NII, SHNI, and BHNI subscription for Molbio Diagnostics IPO will update during the bidding window.
What are Molbio Diagnostics IPO retail allotment chances?
Molbio Diagnostics IPO retail allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
What are Molbio Diagnostics IPO SHNI allotment chances?
Molbio Diagnostics IPO SHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
What are Molbio Diagnostics IPO BHNI allotment chances?
Molbio Diagnostics IPO BHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.
When is Molbio Diagnostics IPO allotment date?
Molbio Diagnostics IPO allotment date is 13 August 2026. Check Molbio Diagnostics IPO Allotment Status on IPOwiz from that day using your PAN.
When does Molbio Diagnostics IPO subscription close?
Molbio Diagnostics IPO subscription is open until 12 August 2026. Apply before the last day closes.
What is Molbio Diagnostics IPO GMP today?
Molbio Diagnostics IPO GMP is ₹170 today (+21.07% over issue price ₹807). See live GMP on the Molbio Diagnostics IPO GMP Today page.
What is Molbio Diagnostics IPO issue price and lot size?
Molbio Diagnostics IPO issue price is ₹807 per share. Lot size is 18 shares. Minimum investment is ₹14,526 per lot. Issue size: ₹939.70 Cr.
When is Molbio Diagnostics IPO listing date?
Molbio Diagnostics IPO listing date is 17 August 2026 on NSE and BSE. Allotment is on 13 August 2026.
How does subscription affect Molbio Diagnostics IPO allotment?
In Molbio Diagnostics IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At - overall, competition is moderate.
For allotment results from 13 August 2026, visit the Molbio Diagnostics IPO Allotment Status page. For listing day updates on 17 August 2026, download the IPOwiz App.
Sources
We match Molbio Diagnostics IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.